China · Delayed Price · Currency is CNY Frontier Biotechnologies Statistics
Total Valuation
SHA:688221 has a market cap or net worth of CNY 10.39 billion. The enterprise value is 10.13 billion.
| Market Cap | 10.39B |
| Enterprise Value | 10.13B |
Important Dates
The next confirmed earnings date is Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688221 has 374.58 million shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | 374.58M |
| Shares Outstanding | 374.58M |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 16.08% |
| Owned by Institutions (%) | 14.91% |
| Float | 214.53M |
Valuation Ratios
The trailing PE ratio is 3,000.09 and the forward PE ratio is 1,154.12.
| PE Ratio | 3,000.09 |
| Forward PE | 1,154.12 |
| PS Ratio | 26.48 |
| PB Ratio | 9.37 |
| P/TBV Ratio | 10.53 |
| P/FCF Ratio | 410.97 |
| P/OCF Ratio | 259.93 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2,925.54 |
| EV / Sales | 25.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 400.76 |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.43.
| Current Ratio | 3.54 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 15.57 |
| Debt / FCF | 18.66 |
| Interest Coverage | 1.14 |
Financial Efficiency
Return on equity (ROE) is 0.31% and return on invested capital (ROIC) is 0.42%.
| Return on Equity (ROE) | 0.31% |
| Return on Assets (ROA) | 0.36% |
| Return on Invested Capital (ROIC) | 0.42% |
| Return on Capital Employed (ROCE) | 0.70% |
| Weighted Average Cost of Capital (WACC) | 8.75% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | 11,026 |
| Employee Count | 314 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +139.67% in the last 52 weeks. The beta is 0.88, so SHA:688221's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +139.67% |
| 50-Day Moving Average | 20.92 |
| 200-Day Moving Average | 19.56 |
| Relative Strength Index (RSI) | 77.73 |
| Average Volume (20 Days) | 17,975,416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688221 had revenue of CNY 392.19 million and earned 3.46 million in profits. Earnings per share was 0.01.
| Revenue | 392.19M |
| Gross Profit | 308.24M |
| Operating Income | 10.35M |
| Pretax Income | 3.46M |
| Net Income | 3.46M |
| EBITDA | 29.59M |
| EBIT | 10.35M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 729.72 million in cash and 471.59 million in debt, with a net cash position of 258.13 million or 0.69 per share.
| Cash & Cash Equivalents | 729.72M |
| Total Debt | 471.59M |
| Net Cash | 258.13M |
| Net Cash Per Share | 0.69 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 2.96 |
| Working Capital | 924.04M |
Cash Flow
In the last 12 months, operating cash flow was 39.96 million and capital expenditures -14.69 million, giving a free cash flow of 25.27 million.
| Operating Cash Flow | 39.96M |
| Capital Expenditures | -14.69M |
| Depreciation & Amortization | 19.25M |
| Net Borrowing | 104.83M |
| Free Cash Flow | 25.27M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 78.60%, with operating and profit margins of 2.64% and 0.88%.
| Gross Margin | 78.60% |
| Operating Margin | 2.64% |
| Pretax Margin | 0.88% |
| Profit Margin | 0.88% |
| EBITDA Margin | 7.55% |
| EBIT Margin | 2.64% |
| FCF Margin | 6.44% |
Dividends & Yields
SHA:688221 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 223.76% |
| Buyback Yield | -0.42% |
| Shareholder Yield | -0.42% |
| Earnings Yield | 0.03% |
| FCF Yield | 0.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:688221 has an Altman Z-Score of 4.31 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.31 |
| Piotroski F-Score | 7 |